Professional
Added to YB: 2025-07-17
Pitch date: 2025-07-11
TEM [bullish]
Tempus AI, Inc.
+22.52%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$12.5B
Pitch Price
$57.63
Price Target
N/A
Dividend
N/A
EV/EBITDA
-82.74
P/E
-59.11
EV/Sales
11.84
Sector
Life Sciences Tools and Services
Category
growth
Patient Capital Management New Position: Tempus AI, Inc.
TEM (new position): Leading precision medicine platform transforming cancer care through AI. Three synergistic segments: genomics, data/services, and AI apps create moat and world's largest molecular cancer database. On track for $1B revenue, EBITDA profitable this year. Expanding beyond oncology into cardiology, neuropsychology, radiology. Well-positioned for healthcare AI disruption.
Read full article (1 min)